Please login to the form below

Not currently logged in
Email:
Password:

DMO

This page shows the latest DMO news and features for those working in and with pharma, biotech and healthcare.

NICE backs Bayer’s Eylea as first-line BRVO treatment

NICE backs Bayer’s Eylea as first-line BRVO treatment

vein occlusion ( CRVO), diabetic macular oedema ( DMO), and myopic choroidal neovascularisation (mCNV).

Latest news

  • NICE backs Bayer's Eylea in diabetic eye condition NICE backs Bayer's Eylea in diabetic eye condition

    Bayer's Eylea and Allergan's Ozurdex have been recommended for use on the NHS in England to treat diabetic macular oedema (DMO). ... For DMO Eylea is given as a 2mg intravitreal injection every month for five months, followed by one injection every two

  • Roche, Novartis and Bayer gain NICE recommendations Roche, Novartis and Bayer gain NICE recommendations

    In the draft final appraisal determination NICE recommends Eylea for the treatment of patients with diabetic macular oedema (DMO) - a condition that affects around 50, 000 people in the UK.

  • NICE recommends Ozurdex for diabetic eye condition NICE recommends Ozurdex for diabetic eye condition

    The National Institute for Health and Care Excellence (NICE) has issued draft guidance recommending the dexamethasone intravitreal implant for the treatment of diabetic macular oedema (DMO). ... The eye indication was approved for DMO in the EU in

  • Novartis launches another localised NHS eye service in UK Novartis launches another localised NHS eye service in UK

    The new services in Coventry provides care for conditions such as wet age-related macular degeneration (wet AMD), visual impairment due to diabetic macular oedema (DMO) or visual impairment due to

  • Germany's IQWiG delivers bad news for Bayer’s Eylea Germany's IQWiG delivers bad news for Bayer’s Eylea

    Eylea (aflibercept) has been sold in Germany for diabetic macular oedema (DMO) since August, but the German Institute for Quality and Efficiency in Health Care (IQWiG) now says it provides no ... The G-BA had earlier decided that Eylea would be compared

More from news
Approximately 3 fully matching, plus 8 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Makara Health

Independent healthcare communications agency with a passion to develop inspirational ideas that create sustained and positive change. Whether it is...

Latest intelligence

The gene therapy revolution
Gene therapies are bringing new hope for many people with diseases caused by genetic disorders...
PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...

Infographics